Pharma Companies are going to transform the Post Traumatic Stress Disorder PTSD Market

1. Pharma Companies are going to transform the Post Traumatic Stress Disorder (PTSD) Market delveinsight2208.blogspot.com/2022/09/pharma-companies-are-going-to-transform.html What is Driving the Post Traumatic Stress Disorder (PTSD) Treatment Market? What is Post Traumatic Stress Disorder (PTSD)? Post-Traumatic Stress Disorder (PTSD) is defined as the complex cognitive, emotional, and behavioral consequences that are caused due to psychological trauma. In Post- Traumatic Stress Disorder, the person suffers from intrusive thoughts, nightmares, flashbacks, and terrifying episodes of stress and sleepless nights. The symptoms of Post-Traumatic Stress Disorder occur soon in a month or less after a stressful experience, although the occurrence of symptoms can be seen late after years. The symptoms that occur during the Post-Traumatic Stress Disorder cause substantial issues in society and the workplace, as well as in the personal relationships of the person. PTSD symptoms can also harm the daily routine of a person. Post-Traumatic Stress Disorder Epidemiology Insights- According to the DelveInsight analysis, the prevalence of Post-Traumatic Stress Disorder is highest in the United States, affecting 3.5% of the adults in the US every year. And 1 out of 11 people is estimated to be diagnosed with PTSD in their lifetime. Moreover, Women are more prone to develop PTSD than Men. According to the DelveInsight’s Post- Traumatic Stress Disorder Epidemiology Forecast Report, the prevalence of PTSD in the 7MM affected the population of more than 13 million in the year 2021, out of which the diagnosed prevalent cases were around 5 million. Post-Traumatic Stress Disorder Market Insights- The market value of Post-Traumatic Stress Disorder in the 7MM was estimated at USD 1,740.2 million in 2021, which is further estimated to grow in the future growth with a significant CAGR owing to the increase in the prevalence and rise in initiatives to create public awareness and knowledge of the disease. 1/2

2. Moreover, the dynamics of the PTSD treatment market are expected to change in the future due to several factors. One of the main reasons which are driving the PTSD treatment market is the introduction of novel drugs and therapeutic drugs, which will give patients hope as alternate options for PTSD treatment and will have a positive impact on the Post-Traumatic Stress Disorder market. Key companies in the Post-Traumatic Stress Disorder market- Several companies are working on developing therapeutic drugs, and many drugs are underlying in the Post-Traumatic Stress Disorder Pipeline. The companies are listed as- Pfizer Bionomics AstraZeneca Alto Biosciences Sage Therapeutics Nobilis Therapeutics Jazz Pharmaceuticals Tonix Pharmaceuticals Post-Traumatic Stress Disorder Emerging Therapies- There are several companies that are actively developing therapies for Post-Traumatic Stress Disorder. Here is a list of the promising Post-Traumatic Stress Disorder drugs in various stages of development are NYX-783, JZP150, Brexpiprazole and Zoloft Combination, BNC210, and others. Expected Roadblocks: The Post Stress Disorder Market is growing but there there are still a few barriers that are limiting the growth of the Post Stress Disorder Market. One of the reasons is, that the heterogeneity of the symptoms and delayed onset of PTSD are acting as a barrier to the growth of the Post Traumatic Stress Disorder treatment market. 2/2